Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,928 public trials 460 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Active, Not Recruiting

Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS

NCT03535298

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • University of Colorado-Anschutz Medical Campus Aurora, Colorado, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada, United States
View all 30 locations
View Trial Details
Active, Not Recruiting

ABA-101 in Participants With Progressive Multiple Sclerosis

NCT06566261

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Rutgers, Robert Wood Johnson Medical School New Brunswick, New Jersey, United States
  • Cleveland Clinic Mellen Center Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

NCT04280718

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Investigator site 0010065 Birmingham, Alabama, United States
  • Investigator site 0010013 Phoenix, Arizona, United States
  • Investigator site 0010055 Scottsdale, Arizona, United States
  • Investigator site 0010032 Carlsbad, California, United States
View all 147 locations
View Trial Details
Active, Not Recruiting

Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease

NCT04578639

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Nordlandsykehuset HF Bodø, Norway
  • Vestre Viken sykehus Drammen, Norway
  • Sørlandet Sykehus Kristiansand, Norway
View Trial Details

Related conditions